Insider · CIK 0001533451

Hoerter Steven L.

Reports to the SEC for 9 companies · CARMEL, IN

sec.gov

Transactions

Companies

Filings

CIK

0001533451

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-08-03	MBXMBX Biosciences, Inc. · Stock option (right to buy)A Award	Director, President and CEO	AAward	+331K sh	—	—	331,000
2026-08-03	MBXMBX Biosciences, Inc.A Award	Director, President and CEO	AAward	+71K sh	—	—	82,938
2026-06-24	CCCCC4 Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+62K sh	—	—	62,000
2026-06-04	MBXMBX Biosciences, Inc. · Stock option (right to buy)A Award	Director, President and CEO	AAward	+12.5K sh	—	—	12,500
2026-05-01	MBXMBX Biosciences, Inc. · Stock option (right to buy)A Award	Director, President and CEO	AAward	+74.2K sh	—	—	74,249
2026-05-01	MBXMBX Biosciences, Inc.A Award	Director, President and CEO	AAward	+11.9K sh	—	—	11,938
2026-01-02	ORICOric Pharmaceuticals, Inc. · Stock Option (right to buy)A Award	Director	AAward	+40K sh	—	—	40,000
2025-11-22	MBXMBX Biosciences, Inc. · Stock option (right to buy)A Award	Director, President and CEO	AAward	0 sh	—	—	0
2025-11-22	MBXMBX Biosciences, Inc. · Stock option (right to buy)A Award	Director, President and CEO	AAward	+8,000 sh	—	—	8,000
2025-11-06	MBXMBX Biosciences, Inc. · Stock option (right to buy)A Award	Director, President and CEO	AAward	+100K sh	—	—	100,000
2025-11-06	MBXMBX Biosciences, Inc. · Stock option (right to buy)A Award	Director, President and CEO	AAward	+33.8K sh	—	—	33,751
2025-10-17	MBXMBX Biosciences, Inc.P Purchase	Director, President and CEO	PPurchase	+20K sh	$13.25	+$265K	20,000
2025-06-18	CCCCC4 Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+35.5K sh	—	—	35,500
2025-06-05	MBXMBX Biosciences, Inc. · Stock option (right to buy)A Award	Director, President and CEO	AAward	+16K sh	—	—	16,000
2025-04-07	MBXMBX Biosciences, Inc. · Stock option (right to buy)A Award	Director, President and CEO	AAward	+32K sh	—	—	32,000
2025-01-02	ORICOric Pharmaceuticals, Inc. · Stock Option (right to buy)A Award	Director	AAward	+35K sh	—	—	35,000
2024-11-19	CCCCC4 Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+65K sh	—	—	65,000
2024-06-12	ORICOric Pharmaceuticals, Inc. · Stock Option (right to buy)A Award	Director	AAward	+25.6K sh	—	—	25,600
2024-06-11	Deciphera Pharmaceuticals, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−396K sh	—	—	0
2024-06-11	Deciphera Pharmaceuticals, Inc.U Disposition from Tender	Director, President and CEO	UDisposition from Tender	−72.8K sh	—	—	0
2024-06-11	Deciphera Pharmaceuticals, Inc.D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−286K sh	—	—	72,763
2024-06-11	Deciphera Pharmaceuticals, Inc.A Award	Director, President and CEO	AAward	+286K sh	—	—	358,838
2024-06-11	Deciphera Pharmaceuticals, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−415K sh	—	—	0
2024-06-11	Deciphera Pharmaceuticals, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−298K sh	—	—	0
2024-06-11	Deciphera Pharmaceuticals, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−250K sh	—	—	0
2024-06-11	Deciphera Pharmaceuticals, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−270K sh	—	—	0
2024-02-15	Deciphera Pharmaceuticals, Inc.Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+298K sh	—	—	298,100
2023-12-13	Deciphera Pharmaceuticals, Inc.S Sale	Director, President and CEO	SSale	−30.7K sh	$15.37	−$471K	72,763
2023-12-12	Deciphera Pharmaceuticals, Inc.A Award	Director, President and CEO	AAward	+62.5K sh	—	—	103,427
2023-10-30	Deciphera Pharmaceuticals, Inc.S Sale	Director, President and CEO	SSale	−21.6K sh	$12.02	−$259K	40,927
2023-10-28	Deciphera Pharmaceuticals, Inc.A Award	Director, President and CEO	AAward	+62.5K sh	—	—	62,500
2023-06-14	ORICOric Pharmaceuticals, Inc. · Stock Option (right to buy)A Award	Director	AAward	+20.5K sh	—	—	20,500
2023-03-21	Deciphera Pharmaceuticals, Inc.S Sale	Director, President and CEO	SSale	−7,500 sh	$15.57	−$117K	0
2023-02-15	Deciphera Pharmaceuticals, Inc.Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+250K sh	—	—	250,000
2023-02-14	Deciphera Pharmaceuticals, Inc.S Sale	Director, President and CEO	SSale	−30K sh	$16.00	−$481K	7,500
2022-06-17	ORICOric Pharmaceuticals, Inc. · Stock Option (right to buy)A Award	Director	AAward	+50.3K sh	—	—	50,283
2022-03-21	Deciphera Pharmaceuticals, Inc.F Tax Payment	Director, President and CEO	FTax Payment	−3,150 sh	$9.11	−$28.7K	37,545
2022-01-18	Deciphera Pharmaceuticals, Inc.Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	−415K sh	—	—	415,000
2021-12-15	Deciphera Pharmaceuticals, Inc.Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+270K sh	—	—	270,357
2021-08-13	ORICOric Pharmaceuticals, Inc. · Stock Option (right to buy)A Award	Director	AAward	+33.3K sh	—	—	33,250
2021-07-15	CONSTELLATION PHARMACEUTICALS INCStock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−26.3K sh	—	—	0
2021-07-15	CONSTELLATION PHARMACEUTICALS INCStock Options (Right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−13.2K sh	—	—	0
2021-07-15	CONSTELLATION PHARMACEUTICALS INCStock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−26.3K sh	—	—	0
2021-07-15	CONSTELLATION PHARMACEUTICALS INCStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−13.2K sh	—	—	0
2021-07-15	CONSTELLATION PHARMACEUTICALS INCStock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−13.2K sh	—	—	0
2021-06-02	CONSTELLATION PHARMACEUTICALS INCStock Option (Right to Buy)A Award	Director	AAward	+13.2K sh	—	—	13,171
2021-03-18	Deciphera Pharmaceuticals, Inc.F Tax Payment	Director, President and CEO	FTax Payment	−700 sh	$42.39	−$29.7K	43,145
2021-03-18	Deciphera Pharmaceuticals, Inc.F Tax Payment	Director, President and CEO	FTax Payment	−2,450 sh	$43.19	−$106K	40,695
2021-02-16	Deciphera Pharmaceuticals, Inc.Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	−210K sh	—	—	210,000
2021-01-21	Deciphera Pharmaceuticals, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+1,078 sh	$25.40	+$27.4K	43,845

Recent filings

Accepted (ET)
Aug 44
Hoerter Steven L.0001193125-26-331639
SEC(opens sec.gov)
Jun 264
Hoerter Steven L.0001470831-26-000670
SEC(opens sec.gov)
Jun 54
Hoerter Steven L.0001193125-26-258429
SEC(opens sec.gov)
May 44
Hoerter Steven L.0001193125-26-202615
SEC(opens sec.gov)
Apr 224/A
Hoerter Steven L.0001193125-26-168530
SEC(opens sec.gov)
Apr 224/A
Hoerter Steven L.0001193125-26-168524
SEC(opens sec.gov)
Jan 64
Hoerter Steven L.0001533451-26-000002
SEC(opens sec.gov)
Nov 254
Hoerter Steven L.0001193125-25-294675
SEC(opens sec.gov)
Nov 74
Hoerter Steven L.0001193125-25-271118
SEC(opens sec.gov)
Oct 204
Hoerter Steven L.0001193125-25-243653
SEC(opens sec.gov)
Jun 204
Hoerter Steven L.0001662579-25-000042
SEC(opens sec.gov)
Jun 64
Hoerter Steven L.0000950170-25-082713
SEC(opens sec.gov)
Apr 94
Hoerter Steven L.0000950170-25-052313
SEC(opens sec.gov)
Jan 64
Hoerter Steven L.0001415889-25-000788
SEC(opens sec.gov)
Nov 214
Hoerter Steven L.0001662579-24-000108
SEC(opens sec.gov)
Jun 144
Hoerter Steven L.0001415889-24-016909
SEC(opens sec.gov)
Jun 114
Hoerter Steven L.0000950170-24-072196
SEC(opens sec.gov)

Companies

Address

C/O MBX BIOSCIENCES INC. 11711 N. MERIDIAN STREET, SUITE 300

CARMEL, IN, 46032